Peter Popovič
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Biotechnology top 5%
- Microbial Inactivation Methods
Papers in
- Hepatology 14
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Liver Disease and Transplantation 3
-
- Venous Thromboembolism Diagnosis and Management 3
- Co-authors
- Holger Amthauer (1 shared paper)Antonio Gasbarrini (1 shared paper)Peter Bartenstein (1 shared paper)Markus Peck‐Radosavljevic (1 shared paper)Eckart Schott (1 shared paper)Enrico Narciso De Toni (1 shared paper)Heinz-Josef Klümpen (1 shared paper)Maciej Pech (1 shared paper)
In The Last Decade
Peter Popovič
37 papers receiving 702 citations
Peter Popovič's Hit Papers
Peers
Comparison fields: 5 of 50
- Hepatology 367
- Biotechnology 96
- Internal Medicine 22
- Surgery 96
- Ophthalmology 21
Countries citing papers authored by Peter Popovič
This map shows the geographic impact of Peter Popovič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Popovič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Popovič more than expected).
Fields of papers citing papers by Peter Popovič
This network shows the impact of papers produced by Peter Popovič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Popovič. The network helps show where Peter Popovič may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Popovič, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma Hit paper breakdown → | 2019 | 293 |
| 2 | 2018 | 76 | |
| 3 | 2020 | 32 | |
| 4 | 2020 | 28 | |
| 5 | 2005 | 27 | |
| 6 | 2013 | 26 | |
| 7 | 2013 | 24 | |
| 8 | 2015 | 19 | |
| 9 | 2016 | 17 | |
| 10 | 2010 | 15 | |
| 11 | 2009 | 13 | |
| 12 | 2018 | 12 | |
| 13 | 2020 | 12 | |
| 14 | 2020 | 12 | |
| 15 | 2015 | 11 | |
| 16 | Contrast-enhanced ultrasound for assessment of therapeutic response after percutaneous radiofrequency ablation of small renal tumors. | 2016 | 10 |
| 17 | 2021 | 10 | |
| 18 | 2010 | 9 | |
| 19 | 2017 | 9 | |
| 20 | 2019 | 9 |
About Peter Popovič
Peter Popovič is a scholar working on Hepatology, Internal Medicine, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 718 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Abdominal vascular conditions and treatments (3 papers), Liver Disease and Transplantation (3 papers), Colorectal Cancer Surgical Treatments (2 papers), Maternal and fetal healthcare (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Hepatology (367 citations), Biotechnology (96 citations), Internal Medicine (22 citations), Surgery (96 citations) and Ophthalmology (21 citations). Peter Popovič has collaborated with scholars based in Slovenia, Serbia and Austria. Frequent co-authors include Holger Amthauer, Antonio Gasbarrini, Peter Bartenstein, Markus Peck‐Radosavljevic, Eckart Schott, Enrico Narciso De Toni, Heinz-Josef Klümpen, Maciej Pech, Rok Dežman and Max Seidensticker. Their work appears in journals such as CardioVascular and Interventional Radiology, Endocrine Connections, BMC Gastroenterology, Cancers and Radiology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.